Mergers & AcquisitionsBy The Online Investor Staff, updated Thu., Feb. 27, 3:57 PM
|This Slide: #61 of 100|
Slide #61. Roadman Investments Corp. — CLOV Biopharma Corp.
Roadman Investments Corp. (CVE:LITT.CA)
CLOV Biopharma Corp.
Roadman Investments Corp. (TSXV: LITT)(FWB: 1QD)(OTC:RMANF) ("Roadman Investments" or the "Company") is pleased to announce that, further to its press release of February 12, 2020, it has now entered into a Definitive Agreement (the "Agreement") pursuant to which it has acquired all of the issued and outstanding shares of CLOV Biopharma Corp. ("CBP").
Roadman Investments is a global investment management, financial advisory and private equity firm focused on investing growth capital into private and public companies across the Pan-Pacific region in sectors including cleantech and renewable energy, natural resources, chemicals, agriculture and consumer services. As of June 30 2011, the fair value of Co.'s investments was C$2,233,964.
Open the LITT.CA Page at The Online Investor »